Cargando…

684. The impact of rapid molecular respiratory testing on provider and parental decision making for children with respiratory illness evaluated in an ED setting

BACKGROUND: Rapid respiratory testing (RRT) can decrease ancillary testing, length of stay and antibiotic use for hospitalized children. Less is known regarding the impact of RRT in the emergency department (ED). Our objectives were to determine if RRT impacts ED provider clinical decision making, f...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Suchitra, Moss, Angela, Lamb, Molly, Mistry, Rakesh, Dominguez, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778127/
http://dx.doi.org/10.1093/ofid/ofaa439.876
_version_ 1783631065157468160
author Rao, Suchitra
Moss, Angela
Lamb, Molly
Mistry, Rakesh
Dominguez, Samuel
author_facet Rao, Suchitra
Moss, Angela
Lamb, Molly
Mistry, Rakesh
Dominguez, Samuel
author_sort Rao, Suchitra
collection PubMed
description BACKGROUND: Rapid respiratory testing (RRT) can decrease ancillary testing, length of stay and antibiotic use for hospitalized children. Less is known regarding the impact of RRT in the emergency department (ED). Our objectives were to determine if RRT impacts ED provider clinical decision making, family acceptance, and subsequent healthcare visitation for children with influenza-like illness (ILI). METHODS: Randomized controlled trial of children 1 month-18 years of age presenting to a tertiary care pediatric ED with ILI. All children received a nasopharyngeal swab and RRT and were randomized to the intervention group (RRT result given to clinicians/families) or control group (results not available unless obtained clinically). Outcomes included provider decision-making (anti-infective prescribing, ED diagnostic testing, disposition), family acceptance of RRT (willingness to undergo future testing) and repeat healthcare visits (clinic or ED). Providers in the intervention group were surveyed after RRT results were available, and families in both arms were contacted 1 and 10 days later. RESULTS: There were 920 ED visits from 908 enrolled children; 629 (68%) families from both arms and 443 (96%) providers from the intervention arm completed surveys. Most providers (33%) were ED trained and < 5 years post-training (37%). Clinical decisions were changed in 17% of visits based on RRT results, most commonly by ED trained physicians, advanced practice providers, and those < 5 years post-training (Table). The most common decision changes were antiviral use and avoidance of diagnostic tests (Figure). Families were more willing to undergo future RRT if they were in the intervention group, or if RRT results were available in 20 minutes. In the control arm, 22 families (7%) stated they would not have sought additional medical visits if RRT results were available. In the intervention group, 20 families (6.7%) reported that the RRT influenced how their child received care, and 14 families (17%) sought additional care due to RRT results. Figure. Provider Clinical Decision Making Based on Results of Rapid Respiratory Testing, n = 443 [Image: see text] Characteristics of providers and patients by provider decision type [Image: see text] CONCLUSION: RRT impacts clinical decision making for 1 in 5 ED visits, specifically antiviral prescribing and reduced diagnostic testing. Most families were in favor of RRT, which impacts additional health care visits after the ED encounter. DISCLOSURES: Suchitra Rao, MD, BioFire (Grant/Research Support) Molly Lamb, PhD, BioFire (Grant/Research Support) Rakesh Mistry, MD, MSCE, BioFire (Grant/Research Support) Samuel Dominguez, MD, PhD, BioFire (Consultant, Research Grant or Support)
format Online
Article
Text
id pubmed-7778127
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77781272021-01-07 684. The impact of rapid molecular respiratory testing on provider and parental decision making for children with respiratory illness evaluated in an ED setting Rao, Suchitra Moss, Angela Lamb, Molly Mistry, Rakesh Dominguez, Samuel Open Forum Infect Dis Poster Abstracts BACKGROUND: Rapid respiratory testing (RRT) can decrease ancillary testing, length of stay and antibiotic use for hospitalized children. Less is known regarding the impact of RRT in the emergency department (ED). Our objectives were to determine if RRT impacts ED provider clinical decision making, family acceptance, and subsequent healthcare visitation for children with influenza-like illness (ILI). METHODS: Randomized controlled trial of children 1 month-18 years of age presenting to a tertiary care pediatric ED with ILI. All children received a nasopharyngeal swab and RRT and were randomized to the intervention group (RRT result given to clinicians/families) or control group (results not available unless obtained clinically). Outcomes included provider decision-making (anti-infective prescribing, ED diagnostic testing, disposition), family acceptance of RRT (willingness to undergo future testing) and repeat healthcare visits (clinic or ED). Providers in the intervention group were surveyed after RRT results were available, and families in both arms were contacted 1 and 10 days later. RESULTS: There were 920 ED visits from 908 enrolled children; 629 (68%) families from both arms and 443 (96%) providers from the intervention arm completed surveys. Most providers (33%) were ED trained and < 5 years post-training (37%). Clinical decisions were changed in 17% of visits based on RRT results, most commonly by ED trained physicians, advanced practice providers, and those < 5 years post-training (Table). The most common decision changes were antiviral use and avoidance of diagnostic tests (Figure). Families were more willing to undergo future RRT if they were in the intervention group, or if RRT results were available in 20 minutes. In the control arm, 22 families (7%) stated they would not have sought additional medical visits if RRT results were available. In the intervention group, 20 families (6.7%) reported that the RRT influenced how their child received care, and 14 families (17%) sought additional care due to RRT results. Figure. Provider Clinical Decision Making Based on Results of Rapid Respiratory Testing, n = 443 [Image: see text] Characteristics of providers and patients by provider decision type [Image: see text] CONCLUSION: RRT impacts clinical decision making for 1 in 5 ED visits, specifically antiviral prescribing and reduced diagnostic testing. Most families were in favor of RRT, which impacts additional health care visits after the ED encounter. DISCLOSURES: Suchitra Rao, MD, BioFire (Grant/Research Support) Molly Lamb, PhD, BioFire (Grant/Research Support) Rakesh Mistry, MD, MSCE, BioFire (Grant/Research Support) Samuel Dominguez, MD, PhD, BioFire (Consultant, Research Grant or Support) Oxford University Press 2020-12-31 /pmc/articles/PMC7778127/ http://dx.doi.org/10.1093/ofid/ofaa439.876 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Abstracts
Rao, Suchitra
Moss, Angela
Lamb, Molly
Mistry, Rakesh
Dominguez, Samuel
684. The impact of rapid molecular respiratory testing on provider and parental decision making for children with respiratory illness evaluated in an ED setting
title 684. The impact of rapid molecular respiratory testing on provider and parental decision making for children with respiratory illness evaluated in an ED setting
title_full 684. The impact of rapid molecular respiratory testing on provider and parental decision making for children with respiratory illness evaluated in an ED setting
title_fullStr 684. The impact of rapid molecular respiratory testing on provider and parental decision making for children with respiratory illness evaluated in an ED setting
title_full_unstemmed 684. The impact of rapid molecular respiratory testing on provider and parental decision making for children with respiratory illness evaluated in an ED setting
title_short 684. The impact of rapid molecular respiratory testing on provider and parental decision making for children with respiratory illness evaluated in an ED setting
title_sort 684. the impact of rapid molecular respiratory testing on provider and parental decision making for children with respiratory illness evaluated in an ed setting
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778127/
http://dx.doi.org/10.1093/ofid/ofaa439.876
work_keys_str_mv AT raosuchitra 684theimpactofrapidmolecularrespiratorytestingonproviderandparentaldecisionmakingforchildrenwithrespiratoryillnessevaluatedinanedsetting
AT mossangela 684theimpactofrapidmolecularrespiratorytestingonproviderandparentaldecisionmakingforchildrenwithrespiratoryillnessevaluatedinanedsetting
AT lambmolly 684theimpactofrapidmolecularrespiratorytestingonproviderandparentaldecisionmakingforchildrenwithrespiratoryillnessevaluatedinanedsetting
AT mistryrakesh 684theimpactofrapidmolecularrespiratorytestingonproviderandparentaldecisionmakingforchildrenwithrespiratoryillnessevaluatedinanedsetting
AT dominguezsamuel 684theimpactofrapidmolecularrespiratorytestingonproviderandparentaldecisionmakingforchildrenwithrespiratoryillnessevaluatedinanedsetting